Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.

Acquisition is expected to realize over $10M in annual synergies Results in Currax owning the global rights to CONTRAVE® In connection with this transaction, Currax repaid 25% of its outstanding debt Currax anticipates revenues in excess of $1... Biopharmaceuticals, Mergers & Acquisitions Currax Pharmaceuticals, Nalpropion Pharmaceuticals, CONTRAVE
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news